Ocugen, Inc. (OCGN) Financial Statements (2025 and earlier)

Company Profile

Business Address 11 GREAT VALLEY PARKWAY
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments58,51439,46290,93494,95824,0397,444
Cash and cash equivalent58,51439,46277,56394,95824,0397,444
Short-term investments   13,371   
Advances on inventory purchases    4,988  
Asset, held-for-sale, not part of disposal group      7,000
Other undisclosed current assets3,1683,5097,5582,7001,8381,322
Total current assets:61,68242,97198,492102,64625,87815,766
Noncurrent Assets
Property, plant and equipment16,55417,2906,0531,164633222
Restricted cash and investments307  151151151
Other noncurrent assets3,8994,2864,0871,800714668
Total noncurrent assets:20,76021,57610,1403,1151,4991,041
TOTAL ASSETS:82,44264,547108,632105,76127,37616,807
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,4755,11417,9625,0683,3254,166
Employee-related liabilities1,716  
Accounts payable4,2433,1728,0622,3123951,896
Accrued liabilities6,2321,9429,9001,0402,9302,270
Debt 1,326   234172
Other liabilities     10206
Other undisclosed current liabilities9,78711,9754981,93244 
Total current liabilities:21,58817,08918,4607,0003,6144,544
Noncurrent Liabilities
Long-term debt and lease obligation27,3452,8002,2892,9432,2121,235
Long-term debt, excluding current maturities27,3452,8002,2891,7121,8231,072
Liabilities, other than long-term debt3,8774,0943,831  10
Other liabilities564527244  10
Operating lease, liability3,3133,5673,5871,231389163
Other undisclosed noncurrent liabilities    (1,231)(389) 
Total noncurrent liabilities:31,2226,8946,1202,9432,2121,245
Total liabilities:52,81023,98324,5809,9435,8265,789
Equity
Equity, attributable to parent, including:29,63240,56484,05295,81821,55011,018
Common stock2,9152,5672,2171,9951,841527
Treasury stock, value(48)(48)(48)(48)(48)(48)
Additional paid in capital366,938324,191294,874225,53793,05962,019
Accumulated other comprehensive income482026   
Retained earnings (accumulated deficit)(340,221)(286,167)(213,018)(131,667)(73,302)51,480
Other undisclosed equity, attributable to parent  111 (102,960)
Total equity:29,63240,56484,05295,81821,55011,018
TOTAL LIABILITIES AND EQUITY:82,44264,547108,632105,76127,37616,807

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues4,0556,036  43 
Cost of revenue
(Provision for Loan, Lease, and Other Losses)
    (761)  
Gross profit:4,0556,036 (761)43 
Operating expenses(58,812)(71,567)(84,868)(58,028)(21,327)(14,163)
Other undisclosed operating income    761  
Operating loss:(54,757)(65,531)(84,868)(58,028)(21,285)(14,163)
Nonoperating income (expense)7032,4533,517(389)(537)(6,080)
Investment income, nonoperating    11
Other nonoperating income (expense)    (310)183(785)
Interest and debt expense   426(721)(1,768)
Loss from continuing operations before equity method investments, income taxes:(54,054)(63,078)(81,351)(57,991)(22,543)(22,010)
Other undisclosed loss from continuing operations before income taxes    (426)  
Loss from continuing operations before income taxes:(54,054)(63,078)(81,351)(58,417)(22,543)(22,010)
Income tax benefit    52  
Loss from continuing operations:(54,054)(63,078)(81,351)(58,365)(22,543)(22,010)
Loss before gain (loss) on sale of properties:(58,365)(22,543)(22,010)
Other undisclosed net income     7211,768
Net loss:(54,054)(63,078)(81,351)(58,365)(21,822)(20,243)
Other undisclosed net income attributable to parent      
Net loss attributable to parent:(54,054)(63,078)(81,351)(58,365)(21,822)(20,243)
Preferred stock dividends and other adjustments     (12,546) 
Net loss available to common stockholders, diluted:(54,054)(63,078)(81,351)(58,365)(34,368)(20,243)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(54,054)(63,078)(81,351)(58,365)(21,822)(20,243)
Other comprehensive income (loss)28(6)26   
Other undisclosed comprehensive income      
Comprehensive loss:(54,026)(63,084)(81,325)(58,365)(21,822)(20,243)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     (0)
Comprehensive loss, net of tax, attributable to parent:(54,026)(63,084)(81,325)(58,365)(21,822)(20,243)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: